PubRank

M Hørder

Author PubWeight™ 60.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ 2001 3.12
2 Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med 1990 2.15
3 International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase (L-alanine: 2-oxoglutarate aminotransferase, EC 2.6.1.2). J Clin Chem Clin Biochem 1986 1.51
4 Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected acute myocardial infarction. Analysis of 28 months of follow-up in 196 patients. J Am Coll Cardiol 1995 1.36
5 International Federation of Clinical Chemistry (IFCC) Scientific Committee, Analytical Section: approved recommendation (1985) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate aminotransferase (L-aspartate: 2-oxoglutarate aminotransferase, EC 2.6.1.1). J Clin Chem Clin Biochem 1986 1.26
6 An improved PCR-based method for site directed mutagenesis using megaprimers. Mol Cell Probes 1998 1.19
7 Biochemical markers of ischaemia for the early identification of acute myocardial infarction without St segment elevation. Cardiology 2000 1.06
8 Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA. The Committee on Enzymes of the Scandinavian Society for Clinical Chemistry and Clinical Physiology (SCE). Scand J Clin Lab Invest 1979 1.06
9 Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction. Scand J Clin Lab Invest 1993 1.02
10 International federation of clinical chemistry. Scientific committee. Expert panel on enzymes. IFCC document stage 2, draft 1; 1979-11-19 with a view to an IFCC recommendation. IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase. J Clin Chem Clin Biochem 1980 1.00
11 Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet 2004 0.97
12 Long-term variability in serum thyroglobulin and thyroid related hormones in healthy subjects. Acta Endocrinol (Copenh) 1980 0.93
13 Effects of posture on concentrations of blood constituents in healthy adults: practical application of blood specimen collection procedures recommended by the Scandinavian Committee on Reference Values. Scand J Clin Lab Invest 1980 0.93
14 31P-NMR measurements of ATP, ADP, 2,3-diphosphoglycerate and Mg2+ in human erythrocytes. Biochim Biophys Acta 1990 0.92
15 Falsely negative urinary leucocyte counts due to delayed examination. Scand J Clin Lab Invest 1980 0.92
16 The stability of blood, plasma and serum constituents during simulated transport. Scand J Clin Lab Invest 1981 0.90
17 Elevated serum levels of creatine kinase BB in autosomal dominant osteopetrosis type II. Calcif Tissue Int 1991 0.89
18 Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 1994 0.89
19 Reference intervals for trace elements in blood: significance of risk factors. Scand J Clin Lab Invest 1992 0.87
20 Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction. Pharmacogenetics 1998 0.86
21 Current trends in the collaboration of primary health care and clinical chemistry in the Nordic countries. Ups J Med Sci 1986 0.85
22 Vitamin D receptor alleles do not predict bone mineral density or bone loss in Danish perimenopausal women. Bone 1998 0.85
23 Detection of a single base deletion in codon 424 of the low density lipoprotein receptor gene in a Danish family with familial hypercholesterolemia. Atherosclerosis 1994 0.85
24 Phenotypes and genotypes for CYP2D6 and CYP2C19 in a black Tanzanian population. Br J Clin Pharmacol 1999 0.84
25 Analytical goals for the acceptance of common reference intervals for laboratories throughout a geographical area. Scand J Clin Lab Invest 1988 0.84
26 Gradation of unstable angina based on a sensitive immunoassay for serum creatine kinase MB. Br Heart J 1991 0.83
27 Association between CYP1A2 polymorphism and susceptibility to porphyria cutanea tarda. Hum Genet 2000 0.83
28 Gene dosage and down-regulation of the alpha-interferon receptor. Scand J Clin Lab Invest 1992 0.83
29 Risk stratification in suspected acute myocardial infarction based on a sensitive immunoassay for serum creatine kinase isoenzyme MB. A 2.5-year follow-up study in 156 consecutive patients. Cardiology 1992 0.82
30 Clinically applicable mutation screening in familial hypercholesterolemia. Hum Mutat 1996 0.81
31 Molecular genetic analysis of 1053 Danish individuals with clinical signs of familial hypercholesterolemia. Clin Genet 2006 0.80
32 31P NMR measurements of intracellular pH in erythrocytes: direct comparison with measurements using freeze-thaw and investigation into the influence of ionic strength and Mg2+. Magn Reson Med 1987 0.80
33 Evaluation of a clinically applicable mutation screening technique for genetic diagnosis of familial hypercholesterolemia and familial defective apolipoprotein B. Clin Genet 1998 0.80
34 Variability of plasma proteins according to molecular size. Long-term and short-term intra-individual variation. Scand J Clin Lab Invest 1981 0.80
35 A dual label oligonucleotide ligation assay for detection of the CYP2C19*1, CYP2C19*2, and CYP2C19*3 alleles involving time-resolved fluorometry. Ther Drug Monit 1998 0.79
36 Serum lactate dehydrogenase isoenzyme 1 as a marker of testicular germ cell tumor. J Urol 1988 0.79
37 Analytical evaluation of a sensitive enzyme immunoassay for determinations of creatine kinase isoenzyme MB. Clin Chem 1990 0.79
38 Creatine kinase and creatine kinase B-subunit in stable and unstable angina pectoris. Eur J Clin Invest 1986 0.79
39 Production and certification of an enzyme reference material for adenosine deaminase 1 (BCR 647). Clin Chim Acta 2001 0.78
40 Selenium status and the effect of organic and inorganic selenium supplementation in a group of elderly people in Denmark. Scand J Clin Lab Invest 1994 0.78
41 Expression and characterization of six clinically relevant uroporphyrinogen decarboxylase gene mutations. Scand J Clin Lab Invest 2005 0.78
42 Phenotypic presentation of the FH-Cincinnati type 5 low density lipoprotein receptor mutation. Scand J Clin Lab Invest 1996 0.78
43 Screening for mutations in the uroporphyrinogen decarboxylase gene using denaturing gradient gel electrophoresis. Identification and characterization of six novel mutations associated with familial PCT. Hum Mutat 1999 0.78
44 Plasma enzymes in myocardial infarction. An appraisal of quantitative, clinical and pathophysiological information. Scand J Clin Lab Invest 1981 0.78
45 Ways of assessing quality goals for diagnostic tests in clinical situations. Arch Pathol Lab Med 1988 0.78
46 Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis. Hum Mutat 1997 0.78
47 Effects of posture on concentrations of serum proteins in healthy adults. Dependence on the molecular size of proteins. Scand J Clin Lab Invest 1980 0.78
48 [Laboratory medicine in primary health care--extent and costs]. Nord Med 1988 0.78
49 Assessment of the NMR visibility of intraerythrocytic sodium by flame photometric and ion-competitive studies. Magn Reson Med 1989 0.78
50 Reference values for six enzymes in plasma from newborns and women at delivery. Scand J Clin Lab Invest 1979 0.77
51 Correlation between molecular genetic analyses and immunohistochemical evaluation of the epidermal growth factor receptor and p185HER2. Anticancer Res 1998 0.77
52 Discrepancies in assessment of metabolic regulation in insulin-dependent diabetes mellitus--can we do without measurements of glycated haemoglobin? Diabetes Res 1990 0.77
53 The influence of analytical bias on diagnostic misclassifications. Clin Chim Acta 1997 0.77
54 Screening for haemochromatosis: prevalence among Danish blood donors. J Intern Med 1991 0.77
55 Effect of increased gene dosage expression on the alpha-interferon receptors in Down's syndrome. Biochim Biophys Acta 1993 0.77
56 Detection and characterization of a novel splice mutation in the LDL receptor intron 12 resulting in two different mutant mRNA variants. Atherosclerosis 1997 0.77
57 Fluoride, aluminum, and phosphate kinetics in cryolite workers. J Occup Med 1990 0.77
58 Calibration, specificity and trueness of a postheparin plasma lipoprotein lipase assay. Clin Chem Lab Med 2001 0.77
59 Human ventricular myosin light chain isotype 1 as a marker of myocardial injury. Cardiology 1994 0.77
60 [Randomized controlled trial of structured, individualized treatment of type 2 diabetes mellitus. The project of Diabetes Care in General Practice]. Ugeskr Laeger 2001 0.76
61 Increased IFN-alpha-induced sensitivity but reduced reactivity of 2',5'-oligoadenylate synthetase (2,5AS) in trisomy 21 blood lymphocytes. Clin Exp Immunol 1993 0.76
62 Metabolic evaluation of non-insulin-dependent diabetes in primary health care--the clinical usefulness of glycated haemoglobin measurements. Scand J Prim Health Care 1989 0.76
63 Analytical goals for the estimation of non-Gaussian reference intervals. Scand J Clin Lab Invest 1989 0.76
64 Characterization of two isoalleles and three mutations in both isoforms of purified recombinant human porphobilinogen deaminase. Scand J Clin Lab Invest 2005 0.76
65 Discrepancy in HbA1c measurements performed at different local laboratories and at a selected central reference laboratory. Ups J Med Sci 1993 0.76
66 A fast and robust dual-label nonradioactive oligonucleotide ligation assay for detection of factor V Leiden. Thromb Haemost 1997 0.76
67 Limitation of enzymatic models for predicting myocardial infarct size. Br Heart J 1983 0.75
68 Transferability studies for the AACC reference method and the IFCC method for measurement of alkaline phosphatase activity. Clin Chem 1984 0.75
69 [Clinical needs for standardization of HbA1C]. Ugeskr Laeger 1994 0.75
70 Influence of analytical quality on the diagnostic power of a single S-CK B test in patients with suspected acute myocardial infarction. Scand J Clin Lab Invest Suppl 1980 0.75
71 The influence of extracellular magnesium on cell damage induced by ATP depletion in human fibroblasts. Scand J Clin Lab Invest 1991 0.75
72 [Laboratory tests in primary health service. 2. Use of tests in frequent clinical problems]. Nord Med 1988 0.75
73 Production and certification of an enzyme reference material for creatine kinase isoenzyme 2 (CRM 608). Clin Chim Acta 1998 0.75
74 Decreased alanine aminotransferase activity in serum of man during gamma-acetylenic-GABA treatment. Scand J Clin Lab Invest 1980 0.75
75 Series of test results in patients with prostatic cancer: clinical and analytical aspects of interpretation. Scand J Clin Lab Invest Suppl 1985 0.75
76 [Therapy control of perphenazine in paranoid conditions. 1. Organizational aspects]. Ugeskr Laeger 1991 0.75
77 [Deliberations on the future organization of diagnostic and treatment control of hyperlipidemia. Experiences from the county of Funen]. Ugeskr Laeger 1989 0.75
78 [DNA biobanks. Establishment and maintenance]. Ugeskr Laeger 1998 0.75
79 [Distribution of serum total cholesterol in a population with varying risks of cardiovascular disease]. Ugeskr Laeger 1990 0.75
80 Assessing (analytical) quality in clinical chemistry. Review of pertinent literature. Scand J Clin Lab Invest Suppl 1980 0.75
81 A method for determination of zinc in mononuclear leucocytes. J Trace Elem Electrolytes Health Dis 1988 0.75
82 [Home monitoring of blood glucose in children with diabetes mellitus]. Ugeskr Laeger 1986 0.75
83 A reference preparation of creatine kinase BB isoenzyme. Clin Chem 1993 0.75
84 [Assessment of the risk of cardiovascular disease on the basis of total serum cholesterol in a population of young Danish women and men]. Ugeskr Laeger 1990 0.75
85 Screening for haemochromatosis: influence of analytical imprecision, diagnostic limit and prevalence on test validity. Scand J Clin Lab Invest 1991 0.75
86 Analytical goal setting prior to selection of a method for glycated haemoglobin. Scand J Clin Lab Invest 1990 0.75
87 [Clinical relevance of education in medical chemistry]. Nord Med 1982 0.75
88 Serum zinc in homosexual men with antibodies against human immunodeficiency virus. Clin Chem 1988 0.75
89 [Iron stores, iron deficiency and iron supplementation]. Ugeskr Laeger 1991 0.75
90 International Federation of Clinical Chemistry. Committee on Standards. Expert Panel on Enzymes. Approved recommendation (1978) on IFCC methods for the measurement of catalytic concentration of enzymes. Part 1. General considerations concerning the determination of the catalytic concentration of an enzyme in the blood serum or plasma of man. Clin Chim Acta 1979 0.75
91 A review of 23Na nuclear magnetic resonance spectroscopy for the in vitro study of cellular sodium metabolism. Scand J Clin Lab Invest 1990 0.75
92 [Home measurement of blood glucose--quality assessment]. Nord Med 1984 0.75
93 Praecordial ECG mapping in acute anterior myocardial infarction. The evolution of ST segment and Q and R waves. Acta Med Scand 1981 0.75
94 Release of enzymes from cultured fibroblasts induced by lysophosphatidylcholine. Enzyme 1982 0.75
95 The impact of quality control materials on the performance of an internal quality control system: 2. Experiences from S-calcium analysis. Scand J Clin Lab Invest Suppl 1984 0.75
96 The impact of quality control materials on the performance of an internal quality control system: 3. Experiences from S-triiodothyronine analysis. Scand J Clin Lab Invest Suppl 1984 0.75
97 Interaction of clinic and laboratory medicine in future development and application of tumor markers. Scand J Clin Lab Invest Suppl 1985 0.75
98 Genetic diagnosis with the denaturing gradient gel electrophoresis technique improves diagnostic precision in familial hypercholesterolemia. Circulation 1995 0.75
99 Mutation screening by denaturing gradient gel electrophoresis in North American patients with acute intermittent porphyria. Clin Chem 1998 0.75
100 Lack of indication of myocardial cell damage after myocardial ischaemia in patients with severe stable angina. Eur Heart J 1992 0.75
101 [What is normal?]. Ugeskr Laeger 1997 0.75
102 [Clinics for counseling on cancer genetics. Experiences with genetic studies and counseling on familial breast cancer and colorectal cancer]. Ugeskr Laeger 1998 0.75
103 Evolution of ST segment and Q and R waves during early phase of inferior myocardial infarction. Acta Med Scand 1979 0.75
104 [Critical balance between the two cultures in medical education]. Ugeskr Laeger 2000 0.75
105 Goals based on clinical application. Scand J Clin Lab Invest Suppl 1990 0.75
106 [Home measurement of blood glucose. Deliberation before the introduction of the test as part of the treatment]. Ugeskr Laeger 1984 0.75
107 Separate estimation of biological and analytical variance components when quantities and reagents are unstable. Scand J Clin Lab Invest 1995 0.75
108 [Sending blood samples from general practices to a hospital laboratory. I. Questionnaire survey among general practitioners in the County of Funen]. Ugeskr Laeger 1978 0.75
109 Clinical evaluation of models and markers of myocardial ischemia. Ups J Med Sci 1983 0.75
110 [Home measurement of blood glucose. A qualitative evaluation]. Ugeskr Laeger 1984 0.75
111 R325X mutation in exon 15 of the hydroxymethylbilane synthase gene identified in two Danish families with acute intermittent porphyria. Clin Chem 1996 0.75
112 Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques. Scand J Urol Nephrol Suppl 1988 0.75
113 A programme for assigning target values for external quality assessment schemes in countries with no authorized reference laboratories. Annex. Experiences with deviating results on Ektachem 700 XR. Scand J Clin Lab Invest Suppl 1993 0.75
114 Isoenzymes of alkaline phosphatase in serum of patients with prostatic cancer. Scand J Clin Lab Invest Suppl 1985 0.75
115 Current methodologies for measuring S-acid phosphatases in the Nordic countries. An inquiry by the Scandinavian Committee on Enzymes (SCE). Scand J Clin Lab Invest Suppl 1985 0.75
116 31P NMR measurements of intracellular pH and 2,3-diphosphoglycerate in erythrocytes. Scand J Clin Lab Invest 1987 0.75
117 [Costs and prices of laboratory services]. Ugeskr Laeger 1991 0.75
118 [Troponin T in acute myocardial infarction. Diagnosis and prognosis in patients admitted for suspected acute myocardial infarction]. Ugeskr Laeger 1994 0.75
119 [Assessment of risk in patients admitted for observation for suspected acute myocardial infarction based on a sensitive immunoanalysis of serum creatine kinase isoenzyme MB]. Ugeskr Laeger 1993 0.75
120 The Scandinavian Committee on Enzymes (SCE). Scand J Clin Lab Invest Suppl 1985 0.75
121 [Therapy control of perphenazine. 2. Clinical aspects]. Ugeskr Laeger 1991 0.75
122 Lactate dehydrogenase isoenzyme 1 in testis cancer. Lancet 1987 0.75
123 A method for evaluating literature data on trace elements. Acta Pharmacol Toxicol (Copenh) 1986 0.75
124 [Diagnosis of hyperlipidemia in patients admitted with acute myocardial infarction]. Ugeskr Laeger 1989 0.75
125 Mutation screening of the entire coding region of the protoporphyrinogen oxidase gene using denaturing gradient gel electrophoresis and denaturing hplc. Clin Chem 2001 0.75
126 Mutation screening of the codon 3500 region of the apolipoprotein B gene by denaturing gradient-gel electrophoresis. Clin Chem 1995 0.75
127 Effect of extracellular Ca2+ and Mg2+ on enzyme release from quiescent fibroblasts during various exposures. Enzyme 1989 0.75
128 [Medical audit in laboratory medicine. A description of the course and some results]. Ugeskr Laeger 1995 0.75
129 International Federation of Clinical Chemistry (IFCC), Scientific Committee, Analytical Section. Guidelines (1985) for classification, calculation and evaluation of conversion rates in clinical chemistry. J Clin Chem Clin Biochem 1985 0.75
130 [Medical graduates from the Odense University 1972-1998. Recruitment and employment]. Ugeskr Laeger 2000 0.75
131 The impact of quality control materials on the performance of an internal quality control system: 1. General considerations. Scand J Clin Lab Invest Suppl 1984 0.75
132 [Enzyme diagnosis of acute myocardial infarction]. Ugeskr Laeger 1989 0.75
133 Robust nonradioactive oligonucleotide ligation assay to detect a common point mutation in the CYP2D6 gene causing abnormal drug metabolism. Clin Chem 1995 0.75
134 Certification of the mass concentration of creatine kinase isoenzyme 2 (CK-MB) in the reference material BCR 608. Clin Chem Lab Med 2001 0.75
135 [Questions as evident key to knowledge: teaching medical students evidence-based medicine]. Ugeskr Laeger 2001 0.75
136 [Determination of B-hemoglobin and B-glucose in general practice. A qualitative evaluation]. Ugeskr Laeger 1984 0.75
137 [It's about iron]. Ugeskr Laeger 1998 0.75
138 [Hyperlipidemia in patients under 60 years of age admitted for suspected myocardial infarction]. Ugeskr Laeger 1989 0.75
139 International Federation of Clinical Chemistry (IFCC), Scientific Committee, Analytical Section, Expert Panel on Analytical System, Expert Panel on Enzymes. Guidelines (1987) for classification, calculation and validation of conversion rates in clinical chemistry. J Clin Chem Clin Biochem 1987 0.75
140 Identification of phosphorylethanolamine in 31P-NMR spectra of human peripheral blood lymphocytes. Biochim Biophys Acta 1986 0.75
141 The variability of ST segment in the early phase of acute myocardial infarction. Acta Med Scand Suppl 1978 0.75
142 Selection and quality assurance of tests in multicenter trials. Scand J Clin Lab Invest Suppl 1985 0.75
143 Primary human aspartate aminotransferase reference material. The catalytic activity concentration of AST in RM 8430 as measured by the IFCC reference method for AST in 10 enzyme standardization laboratories. Clin Chem 1988 0.75
144 Release of enzymes from quiescent fibroblasts during ATP depletion. Enzyme 1988 0.75
145 Concentration of nickel and chromium in serum: influence of blood sampling technique. J Trace Elem Electrolytes Health Dis 1988 0.75
146 [Molecular effects of vitamin D on cell cycle and oncogenesis]. Ugeskr Laeger 1998 0.75
147 Guidelines (1987) for classification, calculation and validation of conversion rates in clinical chemistry - International Federation of Clinical Chemistry, Scientific Committee, Analytical Section: Expert Panel on Analytical Systems, Expert Panel on Enzymes; IFCC Document Stage 2, Draft 4. J Automat Chem 1987 0.75
148 [Macro creatine kinase. A cause of diagnostic problems in acute myocardial infarction]. Ugeskr Laeger 1989 0.75
149 Denaturing gradient gel electrophoresis analysis of the hemochromatosis (HFE) gene: impact of HFE gene mutations on the manifestation of porphyria cutanea tarda. Clin Chem 1999 0.75
150 [Clinical-chemical testing on admission to Odense Hospital]. Ugeskr Laeger 1990 0.75
151 Praecordial ECG-mapping in acute anterior myocardial infarction: the variability of ST segment, Q and R waves. Scand J Clin Lab Invest 1980 0.75
152 An assessment of dialysis-associated osteodystrophy in long-term peritoneal dialysis. Nephron 1982 0.75
153 Early observations of S-myoglobin in the diagnosis of acute myocardial infarction. The influence of discrimination limit, analytical quality, patient's sex and prevalence of disease. Scand J Clin Lab Invest 1986 0.75
154 [Assessment of medical technology in practice]. Ugeskr Laeger 1998 0.75